Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen.

Sasiela, C.A., Stewart, D.H., Kitagaki, J., Safiran, Y.J., Yang, Y., Weissman, A.M., Oberoi, P., Davydov, I.V., Goncharova, E., Beutler, J.A., McMahon, J.B., O'Keefe, B.R.
Journal   J Biomol Screen.
Species  
Analytes Measured   Caspase-3 , p53 , PARP
Matrix Tested   Cell lysates
Year   2008
Volume   13
Page Numbers   229-37
Application   Phosphoproteins
Abstract
High-throughput screening technologies have revolutionized the manner in which potential therapeutics are identified. Although they are the source of lead compounds for ~65% of anticancer and antimicrobial drugs approved by the Food and Drug Administration between 1981 and 2002, natural products have largely been excluded from modern screening programs. This is due, at least in part, to the inherent difficulties in testing complex extract mixtures, which often contain nuisance compounds, in modern bioassay systems. In this article, the authors present a novel electrochemiluminescent assay system for inhibition of MDM2 activity that is suitable for testing natural product extracts in high-throughput screening systems. The assay was used to screen more than 144,000 natural product extracts. The authors identified 1 natural product, sempervirine, that inhibited MDM2 auto-ubiquitination, MDM2-mediated p53 degradation, and led to accumulation of p53 in cells. Sempervirine preferentially induced apoptosis in transformed cells expressing wild-type p53, suggesting that it could be a potential lead for anticancer therapeutics.

View Publications

Related Products

Apoptosis Whole Cell Lysate Kit
Caspase-3, p53, PARP | Human
Multiplex
Cleaved/Total Caspase-3 Whole Cell Lysate Kit
Caspase-3 | Human
Multiplex
Total p53 Whole Cell Lysate Kit
p53 | Human, Mouse, Rat
Singleplex
Browse Our Products

By Analytes
By Applications
Search
Meso Scale Japan 株式会社